Dr. Dunavin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
505 Parnassus Ave
San Francisco, CA 94143Phone+1 415-476-4029- Is this information wrong?
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
- Ohio State University HospitalResidency, Internal Medicine, 2009 - 2012
- University of Kansas School of MedicineClass of 2009
Certifications & Licensure
- CA State Medical License 2019 - 2025
- MD State Medical License 2015 - 2022
- KS State Medical License 2016 - 2020
- OH State Medical License 2009 - 2017
- DC State Medical License 2013 - 2014
- American Board of Internal Medicine Hematology
Clinical Trials
- Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia Start of enrollment: 2012 Jun 06
Publications & Presentations
PubMed
- A Case of EBV-Negative Aggressive NK-cell Leukemia: Use of Next-Generation Sequencing in Demystifying a Diagnostic Dilemma and Guiding Clinical Care.Vanessa E Kennedy, Roberto Ruiz-Cordero, Diwash Jangam, Kwun Wah Wen, Neil Dunavin, Robert S. Ohgami, Parul Bhargava, Weiyun Z. Ai, Bita Fakhri> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 Jul 1
- 37 citationsWJMSC-derived small extracellular vesicle enhance T cell suppression through PD-L1Meizhang Li, Rupal Soder, Sunil Abhyankar, Haitham Abdelhakim, Mitchell W. Braun, Camille V. Trinidad, Harsh B. Pathak, Ziyan Y. Pessetto, Clayton Deighan, Siddhartha ...> ;Journal of Extracellular Vesicles. 2021 Feb 1
- 1 citationsAdherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer.Mitchell W. Braun, Haitham Abdelhakim, Meizhang Li, Stephen Hyter, Ziyan Y. Pessetto, Devin C. Koestler, Harsh B. Pathak, Neil Dunavin, Andrew K. Godwin> ;Journal for Immunotherapy of Cancer. 2020 Oct 1
- Join now to see all
Press Mentions
- Emerging Agents, Treatment Selection Criteria Key to Improving Outcomes in MyelofibrosisJanuary 20th, 2020
- Dr. Dunavin on Treatment Considerations in MyelofibrosisJanuary 10th, 2020
Hospital Affiliations
- UCSF Medical CenterSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: